Spironolactone therapy in older patients - The impact of renal dysfunction

Archives of Gerontology and Geriatrics

Volumn 35, Issue 1, 2002, Pages 45-49

  Butler, J V ^a   McAvoy, H ^a   McEnroy, D ^a   Mulkerrin, E C ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Ageing; Congestive heart failure; Hyperkalemia; Renal impairment; Spironolactone

Indexed keywords

CREATININE; POTASSIUM; SODIUM; SPIRONOLACTONE; UREA;

AGED; AGING; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; FEMALE; HOMEOSTASIS; HUMAN; HYPERKALEMIA; KIDNEY DYSFUNCTION; MALE; MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PULSE RATE; RISK; SODIUM BLOOD LEVEL;

EID: 0036202848     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(01)00214-X     Document Type: Article

References (7)

1. Potassium homeostasis in the elderly
2. Longitudinal studies on the rate of decline of renal function with age
3. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
4. Age and the renin aldosterone system
5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
6. Effect of ageing on plasma renin and aldosterone in normal man